1
|
MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles.
|
Clin Cancer Res
|
2011
|
1.40
|
2
|
Cell labeling with the positive MR contrast agent Gadofluorine M.
|
Eur Radiol
|
2007
|
1.32
|
3
|
The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells.
|
Contrast Media Mol Imaging
|
2009
|
1.24
|
4
|
Relaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: discrimination of viable from lysed cells.
|
Magn Reson Med
|
2009
|
1.17
|
5
|
MR signal characteristics of viable and apoptotic human mesenchymal stem cells in matrix-associated stem cell implants for treatment of osteoarthritis.
|
Invest Radiol
|
2010
|
1.02
|
6
|
Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells in cartilage defects: in vitro and in vivo investigations.
|
Mol Imaging
|
2012
|
0.97
|
7
|
Labeling human embryonic stem cell-derived cardiomyocytes with indocyanine green for noninvasive tracking with optical imaging: an FDA-compatible alternative to firefly luciferase.
|
Cell Transplant
|
2010
|
0.95
|
8
|
Indocyanine green-enhanced imaging of antigen-induced arthritis with an integrated optical imaging/radiography system.
|
Arthritis Rheum
|
2010
|
0.91
|
9
|
Monitoring of natural killer cell immunotherapy using noninvasive imaging modalities.
|
Cancer Res
|
2010
|
0.91
|
10
|
Synovitis in patients with early inflammatory arthritis monitored with quantitative analysis of dynamic contrast-enhanced optical imaging and MR imaging.
|
Radiology
|
2013
|
0.90
|
11
|
Detection of synovitis in the hands of patients with rheumatologic disorders: diagnostic performance of optical imaging in comparison with magnetic resonance imaging.
|
Arthritis Rheum
|
2012
|
0.89
|
12
|
Somatic differentiation and MR imaging of magnetically labeled human embryonic stem cells.
|
Cell Transplant
|
2012
|
0.89
|
13
|
Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging.
|
Magn Reson Med
|
2010
|
0.84
|